Brown KK - Search Results

1

Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.

Fischer A, Pfalzgraf FJ, Feghali-Bostwick CA, Wright TM, Curran-Everett D, West SG, Brown KK. Fischer A, et al. Among authors: brown kk. J Rheumatol. 2006 Aug;33(8):1600-5. J Rheumatol. 2006. PMID: 16783860

2

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Collard HR, et al. Among authors: brown kk. Am J Respir Crit Care Med. 2003 Sep 1;168(5):538-42. doi: 10.1164/rccm.200211-1311OC. Epub 2003 May 28. Am J Respir Crit Care Med. 2003. PMID: 12773325

3

Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.

Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS. Cosgrove GP, et al. Among authors: brown kk. Am J Respir Crit Care Med. 2004 Aug 1;170(3):242-51. doi: 10.1164/rccm.200308-1151OC. Epub 2004 Apr 29. Am J Respir Crit Care Med. 2004. PMID: 15117744

4

The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis.

Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, King TE Jr, Brown KK. Vourlekis JS, et al. Among authors: brown kk. Am J Med. 2004 May 15;116(10):662-8. doi: 10.1016/j.amjmed.2003.12.030. Am J Med. 2004. PMID: 15121492

5

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.

Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE Jr, Brown KK. Collard HR, et al. Among authors: brown kk. Chest. 2004 Jun;125(6):2169-74. doi: 10.1378/chest.125.6.2169. Chest. 2004. PMID: 15189938

6

Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects.

Brown KK, Raghu G. Brown KK, et al. Clin Chest Med. 2004 Dec;25(4):759-72, vii. doi: 10.1016/j.ccm.2004.08.003. Clin Chest Med. 2004. PMID: 15564021 Review.

7

Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity.

Frankel SK, Cool CD, Lynch DA, Brown KK. Frankel SK, et al. Among authors: brown kk. Chest. 2004 Dec;126(6):2007-13. doi: 10.1378/chest.126.6.2007. Chest. 2004. PMID: 15596706

8

Update in the diagnosis and management of pulmonary vasculitis.

Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK. Frankel SK, et al. Among authors: brown kk. Chest. 2006 Feb;129(2):452-465. doi: 10.1378/chest.129.2.452. Chest. 2006. PMID: 16478866 Review.

9

Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.

Swigris JJ, Olson AL, Fischer A, Lynch DA, Cosgrove GP, Frankel SK, Meehan RT, Brown KK. Swigris JJ, et al. Among authors: brown kk. Chest. 2006 Jul;130(1):30-6. doi: 10.1378/chest.130.1.30. Chest. 2006. PMID: 16840379

10

Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease.

Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK. Fischer A, et al. Among authors: brown kk. Chest. 2006 Oct;130(4):976-81. doi: 10.1378/chest.130.4.976. Chest. 2006. PMID: 17035427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters